Leslie Iversen

Q: What Schools Are Affiliated With Leslie Iversen

Leslie Iversen is affiliated with the following schools: University of Oxford, University of Cambridge

Leslie Iversen's AcademicInfluence.com Rankings

Leslie Iversen

Medical

#175

World Rank

#263

Historical Rank

Pharmacology

#10

World Rank

#14

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Leslie Iversen Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Leslie Lars Iversen , was a British pharmacologist, known for his work on the neurochemistry of neurotransmission. Career and research From 1971 to 1982, Iversen was Director of the MRC Neurochemical Pharmacology Unit in Cambridge. Between 1982 and 1995 he worked as Director of the Merck, Sharp & Dohme Neuroscience Research Centre. In 1995 he became Visiting Professor of Pharmacology at the University of Oxford.

(See a Problem?)

Leslie Iversen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I (1966) (5286)
The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. (1986) (1650)
Handbook of Psychopharmacology (1988) (1622)
Opiate analgesics inhibit substance P release from rat trigeminal nucleus (1977) (955)
The Uptake and Storage of Noradrenaline in Sympathetic Nerves (1967) (841)
Role of Transmitter Uptake Mechanisms in Synaptic Neurotransmission (1971) (755)
Cannabis and the brain. (2003) (708)
Release of dopamine from dendrites in rat substantia nigra (1976) (643)
EFFECTS OF 6‐HYDROXYDOPAMINE ON CATECHOLAMINE CONTAINING NEURONES IN THE RAT BRAIN (1970) (628)
Multiple opiate receptor sites on primary afferent fibres (1980) (618)
Capsaicin-induced depletion of substance P from primary sensory neurones (1978) (593)
The retrograde axonal transport of nerve growth factor. (1974) (555)
Uptake and metabolism of γ-aminobutyric acid by neurones and glial cells (1975) (526)
Dopamine receptors in the brain. (1975) (510)
7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. (1988) (510)
THE UPTAKE OF [3H]GABA BY SLICES OF RAT CEREBRAL CORTEX (1968) (508)
Excitatory amino acids in the brain - focus on NMDA receptors (1987) (499)
A post-mortem study of the cholinergic and GABA systems in senile dementia. (1982) (449)
Frontiers in Catecholamine Research (1976) (442)
The toxicity in vitro of beta-amyloid protein. (1995) (423)
Dopamine: 50 years in perspective (2007) (421)
GABA UPTAKE IN RAT CENTRAL NERVOUS SYSTEM: COMPARISON OF UPTAKE IN SLICES AND HOMOGENATES AND THE EFFECTS OF SOME INHIBITORS (1971) (421)
Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type (1980) (418)
Substance P. (1982) (418)
Neurochemical characteristics of early and late onset types of Alzheimer's disease. (1984) (417)
Increased brain dopamine and dopamine receptors in schizophrenia. (1982) (385)
REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN–II (1966) (369)
Biochemical and anatomical observations on the degeneration of peptide-containing primary afferent neurons after neonatal capsaicin (1981) (368)
Studies of the uptake of 3 H-gaba and ( 3 H)glycine in slices and homogenates of rat brain and spinal cord by electron microscopic autoradiography. (1972) (349)
Catecholamine uptake processes. (1973) (344)
Calcium-dependent release of somatostatin and neurotensin from rat brain in vitro (1978) (344)
Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies. (1978) (332)
Dose-dependent effects of capsaicin on primary sensory neurons in the neonatal rat (1983) (330)
Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. (1966) (305)
Localizing 3H-GABA in Nerve Terminals of Rat Cerebral Cortex by Electron Microscopic Autoradiography (1971) (301)
The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. (1994) (283)
THE UPTAKE OF NORADRENALINE BY THE ISOLATED PERFUSED RAT HEART. (1963) (278)
Trans-synaptic regulation of growth and development of adrenergic neurones in a mouse sympathetic ganglion. (1971) (278)
Inhibition of catecholamine Uptake2 by steroids in the isolated rat heart (1970) (277)
The inhibition of noradrenaline uptake by sympathomimetic amines in the rat isolated heart. (1965) (274)
Multiple tachykinin binding sites in peripheral tissues and in brain. (1986) (268)
Loss of pigmented dopamine-β-hydroxylase positive cells from locus coeruleus in senile dementia of alzheimer's type (1983) (267)
INCREASED BRAIN DOPAMINE AND REDUCED GLUTAMIC ACID DECARBOXYLASE AND CHOLINE ACETYL TRANSFERASE ACTIVITY IN SCHIZOPHRENIA AND RELATED PSYCHOSES (1977) (258)
The Action of Neuroleptic Drugs on Dopamine-Stimulated Adenosine Cyclic 3',5'-Monophosphate Production in Rat Neostriatum and Limbic Forebrain (1974) (256)
GLYCINE UPTAKE IN RAT CENTRAL NERVOUS SYSTEM SLICES AND HOMOGENATES: EVIDENCE FOR DIFFERENT UPTAKE SYSTEMS IN SPINAL CORD AND CEREBRAL CORTEX (1971) (252)
The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: a novel catechol amine uptake process (1997) (227)
Inhibition of noradrenaline uptake by drugs (1965) (221)
Opiate receptors influence vasopressin release from nerve terminals in rat neurohypophysis (1980) (217)
Effects of 6-Hydroxydopamine on Noradrenaline-containing Neurones in the Rat Brain (1969) (217)
Dopamine selectively increases 3H-GABA release from slices of rat substantia nigra in vitro (1977) (214)
Uptake mechanisms for neurotransmitter amines. (1974) (212)
Calcitonin gene-related peptide: novel neuropeptide. (1986) (208)
The substantia innominata in alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes (1982) (205)
Uptake Processes for Biogenic Amines (1975) (203)
Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia. (1979) (200)
Use of catechol O‐methyltransferase for the enzyme radiochemical assay of dopamine (1973) (199)
Neurotransmitter transporters and their impact on the development of psychopharmacology (2006) (198)
Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease. (1986) (194)
RELEASE OF [3H]GAMMA‐AMINOBUTYRIC ACID FROM GLIAL CELLS IN RAT DORSAL ROOT GANGLIA. (1974) (189)
Huntington's chorea. Changes in neurotransmitter receptors in the brain. (1976) (187)
Increased tyrosine hydroxylase activity in the locus coeruleus of rat brain stem after reserpine treatment and cold stress. (1974) (181)
The release of γ‐aminobutyric acid during inhibition in the cat visual cortex (1971) (179)
Autoradiographic localization of 3 H-GABA in rat retina. (1972) (179)
Regional studies of catecholamines in the rat brain. 3. Subcellullar distribution of endogenous and exogenous catecholamines in various brain regions. (1966) (177)
Cannabinoids: a real prospect for pain relief? (2002) (175)
Effect of vasoactive intestinal peptide (VIP) and other peptides on cAMP accumulation in rat brain. (1978) (171)
Reduced glutamic-acid-decarboxylase activity of post-mortem brain in Huntington's chorea. (1973) (169)
Storage and synthesis of norepinephrine in the reserpine-treated rat brain. (1966) (168)
Vasoactive intestinal polypeptide (VIP): vesicular localization and potassium evoked release from rat hypothalamus (1978) (167)
Reduction in the Concentration of Nerve Growth Factor in Mice after Sialectomy and Castration (1973) (166)
Uptake of [3H]glutamic acid in excitatory nerve endings: Light and electronmicroscopic observations in the hippocampal formation of the rat (1979) (164)
Purification and characterisation of a membrane-bound substance-P-degrading enzyme from human brain. (1981) (162)
The role of Uptake2 in the extraneuronal metabolism of catecholamines in the isolated rat heart (1969) (161)
EFFECTS OF 5,6‐DIHYDROXYTRYPTAMINE ON MONOAMINERGIC NEURONES IN THE CENTRAL NERVOUS SYSTEM OF THE RAT (1972) (157)
Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum. (1976) (156)
The interaction between MK-801 and receptors for n-methyl-d-aspartate : Functional consequences (1987) (156)
Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography (1974) (156)
Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. (1974) (153)
SUBCELLULAR DISTRIBUTION OF ENDOGENOUS AND [3H] γ‐AMINOBUTYRIC ACID IN RAT CEREBRAL CORTEX (1969) (152)
Effect of nerve growth factor and its antiserum on tyrosine hydroxylase activity in mouse superior cervical sympathetic ganglion. (1971) (151)
Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype. (1992) (150)
NEURONAL DEGENERATION IN LOCUS CERULEUS AND CORTICAL CORRELATES OF ALZHEIMER DISEASE (1987) (150)
Human brain substance P: distribution in controls and Huntington's chorea (1978) (149)
The Chemistry of the Brain (1965) (146)
Neurotransmitter transporters: fruitful targets for CNS drug discovery (2000) (142)
Role of endogenous substance P in stress-induced activation of mesocortical dopamine neurones (1983) (137)
Uptake, storage and metabolism of norepinephrine in tissues of the developing rat. (1967) (137)
Molecular Pharmacology of Phytocannabinoids. (2017) (137)
Tissue selectivity of substance P alkyl esters: suggesting multiple receptors. (1983) (137)
Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia. (1984) (136)
Alterations of brain neurotransmitter receptor binding in Huntington's chorea (1976) (135)
Substance P: localization in synaptic vesicles in rat central nervous system (1977) (134)
Specific binding of 3H-substance P to rat brain membranes (1980) (133)
The use of autoradiographic techniques for the identification and mapping of transmitter-specific neurones in the brain. (1974) (133)
Phencyclidine, dizocilpine, and cerebrocortical neurons. (1990) (131)
Release and metabolism of substance P in rat hypothalamus (1976) (131)
Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative. (1990) (131)
Vasopressin, oxytocin and neurophysins in the human brain and spinal cord (1984) (130)
The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals. (1966) (130)
Novel quinuclidine-based ligands for the muscarinic cholinergic receptor. (1990) (130)
Catecholamines in the Median Eminence: New Evidence for a Major Noradrenergic Input (1973) (129)
Release of enkephalin from rat globus pallidus in vitro (1978) (128)
Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type (1984) (128)
GABA and benzodiazepine receptors (1978) (126)
EFFECTS OF SURGICAL DECENTRALIZATION AND NERVE GROWTH FACTOR ON THE MATURATION OF ADRENERGIC NEURONS IN A MOUSE SYMPATHETIC GANGLION (1972) (126)
Effects of 6-Hydroxydopamine on CNS Catecholamines, Spontaneous Motor Activity and Amphetamine Induced Hyperactivity in Rats (1970) (126)
The Ferrier lecture, 1983 - Amino acids and peptides: fast and slow chemical signals in the nervous system? (1984) (125)
Enkephalin and opiate narcotics increase cyclic GMP accumulation in slices of rat neostriatum (1976) (125)
A quantitative ultrastructural and biochemical analysis of the process of reinnervation of the superior cervical ganglion in the adult rat. (1974) (124)
Reduced corticol choline acetyltransferase activity in senile dementia of Alzheimer type is not accompanied by changes in vasoactive intestinal polypeptide (1980) (124)
Evidence for opiate receptors on pituicytes (1983) (120)
Dopamine receptors in the retina may all be linked to adenylate cyclase (1979) (117)
Sodium dependence of transmitter uptake at adrenergic nerve terminals. (1966) (114)
Distribution of GABA in post-mortem brain tissue from control, psychotic and Huntington's chorea subjects (1980) (112)
Regional Distribution of Neurotensin in Human Brain (1982) (112)
Selective accumulation of [3H]GABA by stellate cells in rat cerebellar cortexin vivo (1972) (108)
The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart. (1965) (104)
Inhibition of catecholamine Uptake-2 by steroids in the isolated rat heart. (1970) (103)
Pharmacological specificity of synthetic peptides as antagonists at tachykinin receptors (1988) (102)
Neuropeptides: Regulators of Physiological Processes by Fleur L. Strand, MIT Press, 1999. £45.00, $65.00 (xi + 658 pages) ISBN 0 262 19407 4 (1999) (100)
The Science of Marijuana (2018) (96)
The role of post‐synaptic neurones in the biochemical maturation of presynaptic cholinergic nerve terminals in a mouse sympathetic ganglion (1972) (92)
Dopamine and [D-ALA2, D-Leu5]enkephalin inhibit the electrically stimulated neurohypophyseal release of vasopressin in vitro: evidence for calcium-dependent opiate action (1982) (92)
Time course of the effects of 6‐hydroxydopamine on catecholamine‐containing neurones in rat hypothalamus and striatum (1970) (91)
A quantitative comparison of the formation of synapses in the rat superior cervical sympathetic ganglion by its own and by foreign nerve fibres (1976) (89)
THE METABOLISM OF γ‐AMINOBUTYRIC ACID (GABA) IN THE LOBSTER NERVOUS SYSTEM–UPTAKE OF GABA IN NERVE‐MUSCLE PREPARATIONS 1 (1968) (88)
NORADRENALINE METABOLIZING ENZYMES IN NORMAL AND SYMPATHETICALLY DENERVATED VAS DEFERENS (1971) (88)
Hypermethylated SUPERMAN Epigenetic Alleles in Arabidopsis (1997) (88)
Selective extraction of small and large molecules from the cerebrospinal fluid by Purkinje neurons. (1985) (87)
Age and histopathologic heterogeneity in Alzheimer's disease. Evidence for subtypes. (1987) (86)
Muscarinic cholinergic receptors in rat corpus striatum and regulation of guanosine cyclic 3',5'-monophosphate. (1978) (86)
Differences between early and late-onset Alzheimer's disease (1987) (80)
Huntington's chorea: Selective depletion of activity of angiotensin converting enzyme in the corpus striatum (1977) (78)
Synaptosomes: Different Populations storing Catecholamines and Gamma-aminobutyric Acid in Homogenates of Rat Brain (1968) (78)
Regional effects of 6-hydroxydopamine on catecholamine containing neurones in rat brain and spinal cord. (1970) (77)
Synthesis and biological properties of enzyme-resistant analogues of substance P. (1981) (77)
Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens (1969) (77)
ARGININE VASOPRESSIN AND CHOLINE ACETYLTRANSFERASE IN BRAINS OF PATIENTS WITH ALZHEIMER TYPE SENILE DEMENTIA (1980) (76)
Nonopioid neuropeptides in mammalian CNS. (1983) (76)
Long-term effects of exposure to cannabis. (2005) (76)
Brain norepinephrine and dopamine in schizophrenia. (1979) (75)
Inhibition of noradrenaline uptake by sympathomimetic amines (1964) (75)
Substance P analog, DiMe-C7: evidence for stability in rat brain and prolonged central actions. (1982) (75)
Normal cortical concentration of cholecystokinin-like immunoreactivity with reduced choline acetyltransferase activity in senile dementia of Alzheimer type. (1981) (74)
A re-evaluation of the neurochemical and antinociceptive effects of intrathecal capsaicin in the rat (1981) (73)
Differences in the regulation of tyrosine hydroxylase and dopa decarboxylase in sympathetic ganglia and adrenals. (1971) (72)
The development and application of a novel N-terminal directed substance P antiserum. (1980) (72)
DOPAMINE RECEPTORS AND SCHIZOPHRENIA: DRUG EFFECT OR ILLNESS? (1980) (72)
A sensitive double isotope derivative assay to measure release of amino acids from brain in vitro. (1973) (72)
CATECHOLAMINE‐SENSITIVE ADENYLATE CYCLASES IN NERVOUS TISSUES (1977) (71)
Introduction to Neuropsychopharmacology (2008) (71)
The possible existence of multiple receptors for substance P (1982) (70)
Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action. (1983) (70)
CHOLINERGIC DEFICIT IN FRONTAL CEREBRAL CORTEX IN ALZHEIMER'S DISEASE IS AGE DEPENDENT (1981) (70)
Designer psychostimulants: Pharmacology and differences (2014) (68)
Use of ADTN to define specific 3H-spiperone binding to receptors in brain (1978) (68)
Extrahypothalamic vasopressin in human brain (1981) (67)
EFFECTS OF AMINO‐OXYACETIC ACID ON [3H]GABA UPTAKE BY RAT BRAIN SLICES (1973) (66)
Effects of protriptyline on the depletion of catecholamines induced by 6‐hydroxydopamine in the brain of the rat (1970) (66)
Non-adrenergic, non-cholinergic autonomic neurotransmission mechanisms. (1979) (65)
Angiotensin-converting enzyme: presence of high activity in choroid plexus of mammalian brain. (1978) (65)
Regional differences in the response to substance P of the longitudinal muscle and the concentration of substance P in the digestive tract of the guinea-pig (1981) (62)
Increased tyrosine hydroxylase activity of sympathetic ganglia cultured in the presence of dibutyryl cyclic AMP. (1972) (62)
DOPAMINE AND NORADRENALINE IN POST‐MORTEM BRAIN IN HUNTINGTON'S DISEASE AND SCHIZOPHRENIC ILLNESS (1980) (61)
3H-Spiperone binding in normal and schizophrenic post-mortem human brain. (1978) (61)
Uptake and metabolism of gamma-aminobutyric acid by neurones and glial cells. (1975) (61)
Substance P Receptors (1980) (60)
Brain peptides. (1981) (60)
Regional study of 3H-spiperone binding and the dopamine-sensitive adenylate cyclase in rat brain. (1979) (60)
THE UPTAKE OF ADRENALINE BY THE RAT ISOLATED HEART. (1965) (57)
Inhibition of catecholamine uptake in the isolated rat heart by haloalkylamines related to phenoxybenzamine (1972) (57)
Glutamate decarboxylase activity in the rat posterior pituitary, pineal gland, dorsal root ganglion and superior cervical ganglion (1976) (54)
Psychopharmacology of the aging nervous system (1988) (54)
[3H]‐QUINUCLIDINYL BENZILATE BINDING TO MUSCARINIC RECEPTORS IN RAT BRAIN: COMPARISON OF RESULTS FROM INTACT BRAIN SLICES AND HOMOGENATES (1979) (54)
Distribution and release of Substance P in the central nervous system (1978) (53)
Opiate and neuroleptic receptor alterations in human schizophrenic brain tissue. (1980) (51)
Uptake and Localization of Transmitter Amino Acids in the Nervous System (1975) (50)
DIFFERENTIAL EFFECTS OF AGONAL STATUS ON MEASUREMENTS OF GABA AND GLUTAMATE DECARBOXYLASE IN HUMAN POST‐MORTEM BRAIN TISSUE FROM CONTROL AND HUNTINGTON'S CHOREA SUBJECTS (1979) (50)
Substance P degradation by rat brain peptidases: inhibition by SQ 20881. (1979) (49)
Differences in the uptake, storage and metabolism of (+)‐ and (—)‐noradrenaline (1971) (47)
A COMPARISON OF THE NEURAL REGULATION OF TYROSINE HYDROXYLASE ACTIVITY IN SYMPATHETIc GANGLIA OF ADULT MICE AND RATS (1973) (47)
Comparison of the Binding of [3H]Spiperone and [3H]Domperidone in Homogenates of Mammalian Retina and Caudate Nucleus (1981) (45)
Substance P receptors in the nervous system and possible receptor subtypes. (1982) (44)
Inhibition of catecholamine uptake by 6-hydroxydopamine in rat brain. (1970) (43)
The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo. (1993) (43)
Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo. (1994) (43)
Regulation of neuropeptide release (1980) (43)
Localization of tritiated dopamine in the median eminence of the rat hypothalamus by electron microscope autoradiography. (1973) (42)
Reduced activity of angiotensin-converting enzyme in basal ganglia in early onset schizophrenia (1980) (42)
Role of amino acids and peptides in synaptic transmission. (1973) (41)
Diurnal rhythm in rat pineal cyclic nucleotide phosphodiesterase activity (1976) (41)
Modification of an enzyme radiochemical assay procedure for noradrenaline. (1970) (41)
Autoradiographic studies of the retrograde axonal transport of nerve growth factor in mouse sympathetic neurones (1975) (39)
The distribution of multiple opiate receptors in bovine brain (1981) (39)
Neuropeptides — what next? (1983) (39)
Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouse (1987) (38)
GABA pharmacology--what prospects for the future? (2004) (38)
In vitro release of [5-methionine]enkephalin and [5-leucine]-enkephalin from the rat globus pallidus. (1978) (38)
Neuropeptides and their peptidases: Functional considerations (1988) (38)
No Evidence for Lateral Asymmetry of Neurotransmitters in Post‐Mortem Human Brain (1980) (38)
Endogenous cannabinoids (1994) (37)
Effect of butaclamol on dopamine‐sensitive adenylate cyclase in the rat striatum (1975) (37)
Thermoregulation: Effects of Environmental Temperature on Turnover of Hypothalamic Norepinephrine (1969) (37)
Neuroprotective NMDA antagonists: the controversy over their potential for adverse effects on cortical neuronal morphology. (1994) (37)
Differences between high-affinity forskolin binding sites in dopamine-rich and other regions of rat brain. (1988) (37)
Separation of human brain angiotensin-converting enzyme from enkephalin-degrading activity. (1979) (36)
Effect of chlorpromazine and some of its metabolites on the dopamine‐sensitive adenylate cyclase of rat brain striatum (1974) (36)
Changes in the retention and metabolism of 3 H-l-norepinephrine in rat brain in vivo after 6-hydroxydopamine pretreatment. (1971) (36)
Retention of injected catechol amines by the mouse. (1962) (35)
The origin of substance P and acetylcholine projections to the ventral tegmental area and interpeduncular nucleus in the rat. (1977) (35)
Modulation of [3H]Diazepam Binding in Rat Cortical Membranes by GABAA Agonists (1985) (35)
The Monoamine Hypothesis of Depression (2008) (34)
Molecular size of benzodiazepine receptor in rat brain in situ: evidence for a functional dimer? (1982) (34)
Amino acid uptake into human brain tumors. (1974) (33)
Release of somatostatin from extra-hypothalamic rat brain slices: inhibition by dopamine and morphine (1981) (33)
3-Mercaptopropionic acid inhibits GABA release from rat brain slices in vitro (1981) (32)
Extrahypothalamic vasopressin is unchanged in Parkinson's disease and Huntington's disease (1982) (32)
Subcellular distribution of monoamine oxidase activity in rat liver and vas deferens. (1968) (32)
GABA analogues: conformational analysis of effects on [3H]GABA binding to postsynaptic receptors in human cerebellum (1979) (32)
The Pharmacology of LSD: A Critical Review (2010) (32)
Reducing opioid-related deaths in the UK (2016) (32)
Fast and slow chemical signalling in the nervous system (1986) (31)
THE UPTAKE OF CATECHOL AMINES AT HIGH PERFUSION CONCENTRATIONS IN THE RAT ISOLATED HEART: A NOVEL CATECHOL AMINE UPTAKE PROCESS (1997) (30)
A novel series of non‐quaternary oxadiazoles acting as full agonists at muscarinic receptors (1990) (30)
Alteractions in brain opiate receptors in Parkinson's disease (1979) (30)
An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'. (2013) (30)
Separation of catecholamine-storing synaptosomes in different regions of rat brain. (1969) (30)
Neurotransmitters of the cerebral cortex in senile dementia of Alzheimer type. (1982) (29)
Reduced Uptake of Tritiated Noradrenaline in Tissues of Immunosympathectomized Animals (1965) (29)
Reduction of angiotensin-converting enzyme in substantia nigra in early-onset schizophrenia. (1979) (29)
In vitro selectivity of agonists and antagonists for beta 1- and beta 2-adrenoceptor subtypes in rat brain. (1988) (28)
HUMAN BRAIN DISTRIBUTION OF NEUROTENSIN IN NORMALS, SCHIZOPHRENICS, AND HUNTINGTON'S CHOREICS * (1982) (28)
Selective accumulation of ( 3 H)GABA by stellate cells in rat cerebellar cortex in vivo. (1972) (27)
Chemical messengers in the brain (1978) (26)
Cholera toxin induces pineal enzymes in culture. (1976) (26)
GLUTAMIC-ACID DECARBOXYLASE IN SCHIZOPHRENIA (1978) (25)
3H-Substance P binding to guinea-pig ileum longitudinal smooth muscle membranes (1984) (25)
Chromatographic behaviour and post-mortem stability of somatostatin in the rat and mouse brain (1981) (25)
BRAIN BIOCHEMISTRY IN SCHIZOPHRENIA (1978) (24)
Dopaminergic mechanisms in the carp retina: Effects of dopamine, K+ and light on cyclic AMP synthesis (1980) (24)
THIORIDAZINE IS NOT SPECIFIC FOR LIMBIC DOPAMINE RECEPTORS (1982) (24)
Depression and Schizophrenia. A Contribution on their Chemical Pathologies (1978) (24)
Inhibition of [3H]GABA Binding to Postsynaptic Receptors in Human Cerebellar Synaptic Membranes by Carboxyl and Amino Derivatives of GABA (1981) (23)
Neuronal uptake processes for amines and amino acids. (1970) (23)
Evidence for Multiple Muscarinic Receptor Subtypes in Human Brain (1984) (23)
Pharmacology: Substance P equals pain substance? (1998) (23)
Drugs: A Very Short Introduction (2001) (23)
Inhibition of the Extraneuronal Metabolism of Noradrenaline in the Isolated Heart by Adrenergic Blocking Agents (1967) (23)
NEURONAL AND EXTRANEURONAL CATECHOLAMINE UPTAKE MECHANISMS (1973) (23)
Subcellular distribution of endogenous and [3H]-GABA in rat cerebral cortex. (1969) (22)
The Catecholamines (1967) (22)
INHIBITION OF NORADRENALINE UPTAKE BY DRUGS. (1965) (22)
Accumulation of α‐methyltyramine by the noradrenaline uptake process in the isolated rat heart (1966) (22)
Effects of imipramine, desipramine and monoamine oxidase inhibitors on the metabolism and psychomotor stimulant actions of d-amphetamine in mice. (1971) (22)
... harmful to the brain (1996) (22)
Actions of dopaminergic agonists on cyclic AMP production in rat brain homogenates. (1975) (21)
High affinity uptake of neurotransmitter amino acids (1975) (21)
Effect of Psychoactive Drugs on Dopamme(3,4-Dihydroxyphenethylamine)-Sensitive Adenylate Cyclase Activity in Corpus Striatum of Rat Brain (1974) (21)
Regional Differences in the Rate of Turnover of Norepinephrine in the Rat Brain (1966) (21)
6-Hydroxydopamine decreases benzodiazepine but not GABA receptor binding in rat cerebellum (1981) (20)
Behavioral functions of dopamine neurons (2009) (20)
Substrate specificity of the enzyme tonin: cleavage of substance P (1980) (20)
Amyloid diseases: Small drugs lead the attack (2002) (20)
The spontaneous and evoked release of newly synthesized [14C]GABA from rat cerebral cortex, in vitro (1977) (19)
Dopamine and noradrenaline in post-mortem brain in Huntington's disease and schizophrenic illness. (1980) (19)
The subcellular distributijon of catecholamines in normal and tyramine-depleted mouse hearts. (1963) (19)
Non-competitive NMDA antagonists as drugs (1995) (19)
Human Brain Postmortem Studies of Neurotransmitters and Related Markers (1982) (18)
Autoradiographic assessment of the effects of N-methyl-d-aspartate (NMDA) receptor antagonists in vivo (1991) (18)
Further evidence for the existence of multiple receptors for dopamine in the central nervous system. (1980) (18)
Enhancement of H-3-norepinephrine uptake in rat tissues by O-methylated metabolites of catecholamines. (1966) (18)
Hemostatic alterations in patients with benign and malignant colorectal disease during major abdominal surgery. (2001) (18)
Multiple Receptors and Binding Sites for Tachykinins (1987) (18)
Studies of neurotransmitters at the synaptic level (1972) (18)
beta-Lipotropin potently inhibits a purified angiotensin converting enzyme from human brain. (1979) (17)
Inhibition of neuronal GABA uptake and glial beta-alanine uptake by synthetic GABA analogues. (1981) (17)
L-687,306: a functionally selective and potent muscarinic M1 receptor agonist. (1992) (17)
Plasma concentrations of L-dopa and 3-methoxydopa and improvement in clinical ratings and motor performance in patients with Parkinsonism treated with L-dopa alone or in combination with amantadine. (1975) (17)
Anti-anxiety receptors in the brain? (1977) (17)
Neuropeptides: promise unfulfilled? (1995) (17)
Chemical pathways in the brain (1975) (17)
Neuropharmacology: Pathophysiology of schizophrenia — causal role for dopamine or noradrenaline? (1983) (17)
Endogenous GABA release from slices of rat cerebral cortex and hippocampus in vitro (1982) (17)
Effects of GABA, dopamine, and substance P on the release of newly synthesized 3H-5-hydroxytryptamine from rat substantia nigra in vitro (1978) (16)
Metabolism of Catecholamines (1970) (16)
MINIMUM DURATION OF TRANS‐SYNAPTIC STIMULATION REQUIRED FOR THE INDUCTION OF TYROSINE HYDROXYLASE BY RESERPINE IN THE RAT SUPERIOR CERVICAL GANGLION (1974) (16)
Competitive as well as uncompetitive N-methyl-D-aspartate receptor antagonists affect cortical neuronal morphology and cerebral glucose metabolism (1993) (16)
Tritiated peptides. 12. Synthesis and biological activity of [4-3H-Phe8]substance P. (1982) (16)
Stimulation of a dopamine-sensitive adenylate cyclase in homogenates of rat striatum by a metabolite of piribedil (ET 495) (2004) (16)
Subsensitivity of the rat striatal dopaminergic system after treatment with bromocriptine: effects on [3H]spiperone binding and dopamine-stimulated cyclic AMP formation (1978) (16)
Growth and development of sympathetic ganglion: maturation of transmitter enzymes and synapse formation in the mouse superior cervical ganglion. (1971) (16)
Characterisation of tachykinin receptors using selectivity of agonists and antagonists: Evidence for an NK-4 type (1988) (15)
Identification of Transmitter-Specific Neurons in CNS by Autoradiographic Techniques (1978) (15)
Biochemical and Pharmacological Studies of Substance P Receptors (1982) (15)
Evidence for naloxone and opiates as GABA antagonists [proceedings]. (1976) (15)
LSD as an agonist at mesolimbic dopamine receptors (1975) (15)
Neuroleptics and schizophrenia (1978) (14)
Medical uses of marijuana? (1993) (14)
Handbook of Chemical Neuroanatomy???Volume 4: GABA and Neuropeptides in the CNS, Part I (1987) (13)
Which D4 do you have? (1992) (13)
Neurobiology of peptides. (1978) (13)
Chapter 2 Chemical signalling in the nervous system (1986) (13)
Chemical identification of a natural opiate receptor agonist in brain (1975) (13)
The D4 and schizophrenia (1993) (13)
A new method for the microdissection of the human hypothalamus, with mapping of cholinergic, GABA and catecholamine systems in twelve nuclei and areas. (1980) (13)
The metabolism of gamma-aminobutyric acid (GABA) in the lobster nervous system--uptake of GABA in the nerve-muscle preparations. (1968) (13)
New techniques in psychopharmacology (1982) (13)
Dopaminergic abnormalities in postmortem schizophrenic brain. (1980) (13)
Enkephalin: the latest instalment (1976) (12)
Neuropharmacology of peptides (1974) (12)
Chapter 6 – Central Neurotransmitters and the Regulation of Behavior (1975) (11)
Dopamine and homovanillic acid concentrations in the post-mortem brain in schizophrenia [proceedings]. (1979) (11)
Biochemical measurement of muscarinic receptor efficacy and its role in receptor regulation. (1988) (11)
Smoking...harmful to the brain. (1996) (11)
Subcellular distribution of endogenous and (3H) gamma-aminobutyric acid in rat cerebral cortex. (1969) (11)
A Learned Society's Perspective on Publishing (2016) (11)
Function and distribution of peptides in the nervous system. (1985) (11)
Biochemical studies of CNS receptors (1983) (10)
Principles of behavioral pharmacology (1977) (10)
Elevated cerebrospinal fluid substance P in arachnoiditis is reduced by systemic administration of morphine. (1982) (10)
High times for cannabis research. (1999) (10)
Inhibition of substance P release from the isolated rat substantia nigra by GABA [proceedings]. (1977) (10)
Thermoregulation and norepinephrine. (1969) (9)
Effects of opiates and osmotic stimuli on rat neurohypophyseal metabolic activity monitored with [3H]-2-deoxyglucose. (1982) (9)
The release of gamma-aminobutyric acid during inhibition in the cat visual cortex. (1971) (9)
Book Review: Fifty Years On: Looking Back on Some Developments in Neurohumoral Physiology (1982) (9)
Pharmacological approaches to the treatment of ischaemic neuronal damage (1991) (9)
New directions in behavioral pharmacology (1987) (9)
Tissue distribution of substance P in the domestic pig during postnatal development. (1981) (8)
Marijuana and Madness: How cannabis works in the brain (2004) (8)
Analysis of glutamate decarboxylase in post-mortem brain tissue in Huntington's chorea. (1974) (8)
Alterations in brain opiate receptors in Parkinson's disease. (1979) (8)
Cholecystokinin receptors: synthetic antagonists with selectivity for receptor subtypes and possible clinical applications. (1991) (8)
Therapeutic potential of NMDA receptor antagonists as neuroprotective agents. (1990) (8)
The discovery of monoamine transporters and their role in CNS drug discovery (1999) (8)
Comparing cannabis with tobacco: Arithmetic does not add up (2003) (8)
Biology of mood and antianxiety drugs (1978) (7)
Affective disorders : drug actions in animals and man (1978) (7)
Release of gamma-aminobutyric acid (GABA) from lobster inhibitory neurones. (1967) (7)
Synergistic interactions between forskolin, isoprenaline and substance P as secretagogues in rat parotid glands. (1987) (7)
History of Tachykinin Receptors (1994) (7)
How does morphine work? (1996) (7)
Neurochemical findings in Huntington's chorea. (1977) (7)
RIGIDITY IN HUNTINGTON'S CHOREA (1974) (7)
Chemical signalling in the nervous system. (1986) (7)
Morphine selectively blocks dopamine-stimulated cyclic AMP formation in rat neostriatal slices [proceedings]. (1977) (6)
Commentary on Dinan's Hypothesis (1987) (6)
Biogenic amine receptors (1975) (6)
5.2 – ADRENERGIC TRANSMISSION (1971) (6)
1,4-dithiothreitol non-specifically potentiates spasmogen actions on the guinea-pig ileum. (1982) (6)
ASSAY OF NERVE GROWTH FACTOR (NGF) IN MOUSE TISSUE AND THE ROLE OF NGF AND DEPOLARIZING STIMULI IN THE LONG-TERM REGULATION OF TYROSINE HYDROXYLASE ACTIVITY IN ADRENERGIC NEURONS (1974) (6)
Chapter 51: Approaches to cholinergic therapy in Alzheimer's disease (1993) (6)
The effect of stimulation of inhibitory pathways on the release of endogenous gamma-aminobutyric acid from the rat cerebral cortex. (1970) (6)
How cannabis works in the brain (2011) (6)
EFFECTS OF CAPSAICIN ON DORSAL-ROOT AFFERENTS (1982) (6)
Dopaminergic mechanisms in schizophrenia. (1977) (5)
Dopamine in the brain and its possible role in madness (1976) (5)
Formation and release of 3H-tryptamine from 3H-tryptophan in rat spinal cord slices. (1974) (5)
Pharmacology and Treatments (2007) (5)
The possible role of neuropeptides in the pathophysiology of rheumatoid arthritis. (1985) (5)
Drugs, Neurotransmitters, and Behavior (2012) (5)
Catecholamine uptake sites in the rat heart after 6-hydroxydopamine treatment and in a genetically hypertensive strain (2004) (5)
Regulation of the development of choline acetyl transferase in presynaptic nerves by post-synaptic neurones in mouse sympathetic ganglion. (1971) (5)
Substance P analog, DiMe-C7: evidence for stability in rat brain and prolonged central actions A.S. Eison, S.D. Iversen, B.E.B. Sandberg, S.P. Watson, M.R. Hanley and L.L. Iversen, Science, 215 (1982) 188–190 (1982) (5)
Approaches to rational drug development in Alzheimer's disease. (1993) (5)
Biochemistry of Biogenic Amines (2012) (5)
AUTORADIOGRAPHIC LOCALIZATION OF NEUROTRANSMITTER RECEPTORS ON SENSORY NEURONS (1982) (5)
Regulation of GABA release by dopamine in the rat substantia nigra. (1978) (5)
GABA — Biochemistry and CNS functions, P. Mandel, F.V. DeFeudis (Eds.). Plenum Press, Baltimore (1979), ISBN: 0 306 40325 0 (1980) (4)
Neuropeptide K in the rat central nervous system (1988) (4)
2627 – USE OF 2-AMINO-6,7-DIHYDROXYTETRALIN (ADTN) TO DEFINE SPECIFIC BINDING OF 3H-SPIPERONE TO DOPAMINE (DA) RECEPTORS IN RAT BRAIN (1978) (4)
Neuropsychological Rehabilitation: A Modular Handbook “Neural Repair, Transplantation and Rehabilitation”, by Roger A. Barker, Stephen B. Dunnett, Psychology Press, Taylor & Francis Group, Hove, 1999, 339pp. (2000) (4)
Regulation of Neuropeptide Release in Rat Brain (1979) (4)
Probes for neurochemical target sites (1991) (4)
Ubiquitous neuronal peptides (1978) (4)
The effects of neonatal capsaicin treatment on dorsal root afferents (1981) (4)
GABA in nervous system function (Kroc Foundation series, vol. 5), by E. Roberts, T. N. Chase and D. B. Tower (eds.), xv + 554 pages, 159 illustrations, 75 tables, Raven Press, New York, N. Y., 1976, US$ 25.00 (1977) (4)
Monoamine oxidase and catechol-O-methyl transferase activities in cat nictitating membrane and rat and guinea-pig vas deferens after sympathectomy. (1968) (4)
Cannabinoids in pain management. Few well controlled trials of cannabis exist for systemic review. (2001) (4)
Effect of vasoactive intestinal peptide (VIP) and other neuropeptides on cAMP accumulation in brain slices [proceedings]. (1978) (4)
Does Cannabis Cause Schizophrenia (2007) (4)
Yet another opioid peptide? (1982) (4)
SYMPOSIUM ON NOVEL TRANSMITTER SUBSTANCES - CHAIRMAN'S INTRODUCTION (1976) (4)
Characteristics of Noradrenaline uptake in the iris/ciliary body and other peripheral tissues of the rat (2004) (4)
Heptylphysostigmine — Novel Acetylcholinesterase Inhibitor: Biochemical and Behavioral Pharmacology (1991) (4)
Non-selective inhibition of GABA and 5-HT uptake systems in rat brain by N-n-alkyl hydroxybenzylamine and N-n-alkyl phenylethylamine derivatives. (1985) (4)
The noradrenergic locus coeruleus by P.A.M. Van Dongen, Ph. D. Thesis, University of Nijmegen, 361 pages, Krips Repro B.V., Meppel, 1980 (1982) (4)
Neurotoxin‐Related Research: From the Laboratory to the Clinic (1992) (4)
Amino acid neurotransmitters (1975) (3)
No cloning, no shelf-life: Neurotransmitters, drugs and disease edited by R. A. Webster and C. C. Jordan, Blackwell Scientific Publications, 1989. £19.50 (474 pages) ISBN 0 632 00717 6 (1990) (3)
Biochemical principles and techniques in neuropharmacology (1975) (3)
Catecholamine receptors detected (1975) (3)
Effects of dopaminergic agonist and antagonist drugs on cyclic 3',5' adenosine monophosphate (cyclic AMP) production in rat brain homogenates (1974) (3)
Hans Thoenen: A modest man whose discoveries had a lasting impact on modern neuroscience (2012) (3)
Uptake and metabolism of 3H-noradrenaline by normal and by denervated vasa deferentia of guinea-pigs and rats. (1969) (3)
Trans-synaptic regulation of tyrosine hydroxylase activity in adrenergic neurones: Effect of potassium concentration on cultured sympathetic ganglia (2004) (3)
Neuropharmacology: Super-potent serotonin blockers (1985) (3)
Pharmacological approaches to neuropeptide function: substance P (1984) (3)
Structure activity relationships for agonist and antagonist drugs at pre- and postsynaptic receptor sites in rat brain. (1975) (3)
Molecular neuroanatomy (1974) (3)
Neurotransmitters and CNS disease. Introduction. (1982) (3)
Describing the brain (1976) (3)
A re-evaluation of the neurochemical and antinociceptive effects of intrathecal capsaicin in the rat J.I. Nagy, P.C. Emson and L.L. Iversen, Brain Res., 211 (1981) 497–502 (1982) (3)
Cannabis and the law — high time for reform? (2004) (3)
Morphine and cyclic nucleotides (1975) (3)
Neurosciences Research (1969) (2)
Substance P: Inactivation in CNS, Enzymatically Resistant Analogue and Development of "Brain Selective" Agonist (1983) (2)
Macromolecules in synaptic function. (1970) (2)
Rita Levi-Montalcini: Neuroscientist par excellence (2013) (2)
Dopaminergic Mechanisms in Schizophrenia and Their Relevance to Therapeutics and Aetiology (1977) (2)
Remembrance: Leslie L. Iversen, Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Harlow, England. "The Axelrod Lab, 1964-1965". (1992) (2)
Dopamine receptors. The D4 and schizophrenia. (1993) (2)
The cell surface and neuronal function. Cell surface reviews, 6 C. W. Cotman, G. Poste and G. L. Nicolson, eds. New York: Elsevier-North Holland (1980). 546 pp. $99.50 (1981) (2)
Co-transmitters, modulation, and the peripheral nervous system (1979) (2)
Uptake and release of GABA and GABA in Huntington's chorea [proceedings]. (1977) (2)
BIOCHEMICAL AND ANATOMICAL EFFECTS OF ANTIBODIES AGAINST NERVE GROWTH-FACTOR ON DEVELOPING RAT DORSAL ROOT-GANGLIA (1983) (2)
Substance P. (1982) (2)
Pharmacology. Endogenous cannabinoids. (1994) (2)
BRAIN DOPAMINE RECEPTOR DENSITIES IN SCHIZOPHRENICS (1981) (2)
GABA Systems in Human Brain in Huntington's Disease and Schizophrenia (1979) (2)
Reply to de Wied and Kastin (2000) (1)
Heroin and Other Opiates (2009) (1)
What Next? A Hundred Years of Cannabis Reports (2007) (1)
The present status of benzodiazepines in psychopharmacology. (1980) (1)
Pre and postsynaptic actions of neuroleptic drugs (1975) (1)
Other Interneuronal Signals (2009) (1)
Neuronal uptake processes for amine and amino acid transmitters (1973) (1)
Test models and new directions in dementia research. (1988) (1)
INTRODUCTION (1982) (1)
Neuronal mechanisms: synaptic function. (1988) (1)
Monitoring Neurotransmitter Release During Behaviour (1987) (1)
Accumulation of alpha-methyltyramine by the noradrenaline uptake process in the isolated rat heart. (1966) (1)
The innervation of the hypothalamic median eminence. (1974) (1)
Nonstriatal dopaminergic neurons: Section VI. Action of dopamine at synaptic level:influence on postsynaptic cells: Introduction: action of dopamine at synaptic level: influence on postsynaptic cells. (1977) (1)
How safe is cannabis (2003) (1)
Handbook of Psychopharmacology (1978) (1)
The Recreational Use of Cannabis (2018) (1)
Medical Uses of Marijuana—Fact or Fantasy? (2018) (1)
Strategies for Treatment of Opiate Abuse (1997) (1)
Subsensitivity of dopamine-stimulated cAMP response in rat striatal and medial frontal cortex slices following treatment with dopamine agonists [proceedings]. (1977) (1)
Origin of dopaminergic afferents to the rat frontal cortex [proceedings]. (1977) (1)
The next happy pill (2003) (1)
The localization of neurotransmitters and receptors in the monkey spinal cord: Effect of dorsal root section (1981) (1)
The Pharmacology of Delta-9-Tetrahydrocannabinol (THC) (2018) (1)
Experimental and Clinical Neurotoxicology, P.S. Spencer, H.H. Schaumberg (Eds), 2nd Edition, 1350 pages, Oxford University Press Inc., USA, April 2000 $145.00. ISBN 0-19-508477-2. (2001) (1)
Regulation of Tyrosine Hydroxylase Synthesis in Organ-Cultured Sympathetic Ganglia (1974) (1)
Symposium on Drugs (1967) (1)
Nociception and pain : proceedings of a Royal Society discussion meeting held on 24 and 25 May 1984 (1985) (1)
Effect of kainic acid injections and other brain lesions on vasoactive intestinal peptide (VIP)-stimulated formation of cAMP in rat brain (1979) (1)
Principles of receptor research (1975) (1)
Dopamine receptors. Which D4 do you have? (1992) (1)
Julius Axelrod. 30 May 1912 — 29 December 2004 (2006) (1)
Proceedings of the International Symposium on Subtypes of Muscarinic Receptors (4th), Held in Wiesbaden (Germany, F.R.) on 20-22 July 1989 (1990) (1)
LACK OF RELATIONSHIP BETWEEN NORADRENALINE CONTENT AND TYROSINE HYDROXYLASE ACTIVITY IN CULTURED SYMPATHETIC GANGLIA (1973) (1)
Glutamate homeostasis revisited - neuronal transport and metabolism (2019) (1)
NEUROPEPTIDE CHANGES IN ALZHEIMERʼS DISEASE (1984) (1)
Early and late onset types of Alzheimer's disease (1984) (1)
Peripheral and Central Effects of THC (2018) (0)
Non-peptide antagonists of CCK-A and CCK-B receptors and their possible therapeutic applications (1992) (0)
Detoxicant Enzymes (1971) (0)
Sleep and a Bedtime Beverage (1972) (0)
The sorry story of drug prohibition (2001) (0)
Role of nuclear imaging in the discovery and development of CNS drugs (1992) (0)
Faculty Opinions recommendation of Levodopa reverses cytokine-induced reductions in striatal dopamine release. (2015) (0)
Neurotoxic Amino Acids and Amino Acid Antagonists as Neuroprotective Agents (1989) (0)
Amphetamines as performance enhancers (2008) (0)
The Effects of Cannabis on the Central Nervous System (2007) (0)
Comparing cannabis with tobacco (2003) (0)
Molecular neurobiology: molecular neurobiology. (1984) (0)
Cost of brain disorders (1992) (0)
An excavation of the drug myth (2001) (0)
BIOCHEMICAL STUDIES OF NEUROTRANSMITTER RECEPTORS IN MAMMALIAN CNS (1981) (0)
Radical remedies (1998) (0)
Biochemistry and mental illness : proceedings of a conference held in the Open University, December 1972 (1973) (0)
Special Topics in Endocrinology & Metabolism, vol 2. (1982) (0)
Characterization of NK1-receptors in guinea-pig ileum: Use of non-peptide NK1-receptor antagonists (1993) (0)
188 – DOPAMINE-LIKE ACTION OF CHOLERA TOXIN IN THE C.N.S. (1977) (0)
Non-selective inhibition of GABA and 5-HT uptake in rat brain by molecules possessing long alkyl side chains. (1984) (0)
Modest Pain Relief from Dronabinol in MS Patients (2004) (0)
Panorama of modern neurobiology (1979) (0)
Handbook of Psychopharmacology (1978) (0)
Brain Peptides: The Role of Peptides in Neuronal Function . Jeffery L. Barker and T. G. Smith, Jr., Eds. Dekker, New York, 1980. xvi, 768 pp., illus. $95. (1981) (0)
Effect of potassium ion concentration on cultured sympathetic ganglia: conclusions about trans-synaptic modulation. (1972) (0)
Treatments for Neurological or Psychiatric Disorders: Principles of Central Nervous System Drug Development (2009) (0)
Opiate analgesics inhibit substance P release from rat trigeminal nucleus T.M. Jessell and L.L. Iversen, Nature (LOnd.), 268 (1977) 549–551 (1979) (0)
CCK Antagonist Potentiation of Opioid Analgesia (2003) (0)
Drugs for cognitive disorders (2012) (0)
Book Review: Psychochemical Research in Man (1970) (0)
Cellular and Molecular Foundations of Neuropsychopharmacology (2009) (0)
Illicit amphetamine use around the world (2008) (0)
The future with amphetamines (2008) (0)
Muscarinic acetylcholine receptors and cyclic GMP in rat brain [proceedings]. (1977) (0)
THE USE OF AUTORADIOGRAPHIC TECHNIQUES FOR THE IDENTIFICATION AND MAPPING OF TRANSMITTER-SPECIFIC NEURONES IN THE BRAIN (1975) (0)
Book Review: Lithium Research and Therapy (1975) (0)
Schizophrenia: Dopaminergic Mechanisms, Aetiology and Therapeutics; Some Questions Answered (2006) (0)
5. Making new medicines (2001) (0)
P. Mandel F.V. DeFeudis (1980) (0)
an NMDA receivers (1987) (0)
Antidepressants (2022) (0)
Approaches to cholinergic therapy in Alzheimer's disease. (1993) (0)
Proceedings:Pre- and postsynaptic actions of neuroleptic drugs. (1975) (0)
AMINO ACIDS AND PEPTIDES IN CNS – PROSPECTS FOR DESIGN OF NOVEL PSYCHOTROPIC DRUGS (1978) (0)
The toxicity in vitro of fI-amyloid protein* (2005) (0)
3. Drugs as medicines (2001) (0)
Medical Research Council Neurochemical Pharmacology Unit (1974) (0)
Letter: Rigidity in Huntington's chorea. (1974) (0)
Proceedings of the International Symposium on Subtypes of Muscarinic Receptors 2 (2nd) Held in Boston, Massachusetts on August 22-24 1985 (1986) (0)
Pharmacology of neurones (1974) (0)
Faculty of 1000 evaluation for The D3 dopamine receptor: From structural interactions to function. (2016) (0)
Mind and molecules (1997) (0)
Neurotransmitters, Receptors, Transporters (2002) (0)
Is Cannabis a Useful Treatment for Multiple Sclerosis Symptoms (2004) (0)
Plasma concentrations ofL-dopa and3-methoxydopa andimprovement inclinical ratings andmotor performance inpatients withParkinsonism treated withL-dopa alone orincombination withamantadine (1975) (0)
The effect of peptidase inhibitors on the recovery of substance P released from brain slices (1987) (0)
Proceedings: Spontaneous and evoked release of newly synthesized [14C]- GABA from rat brain slices. (1975) (0)
Nuclear Imaging in Drug Development — Introduction (1993) (0)
Neurosciences in the U.K. — not all gloom and doom (1980) (0)
Dale centennial celebrations at Cambridge (1975) (0)
Abstracts Second Congress of the European Society for Clinical Neuropharmacology (1995) (0)
100 and 50 years ago (2002) (0)
Antidepressants and Anxiolytics (2009) (0)
Comprar Introduction To Neuropsychopharmacology | Iversen, Leslie L. | 9780195380538 | Oxford University Press (2009) (0)
Biochemical Pharmacology of Substance P Receptors (1984) (0)
The Pharmacology of Delta-9-Tetrahydrocannabinol (THC), the Psychoactive Ingredient in Cannabis (2007) (0)
Neural Biochemistry (1973) (0)
ANALYSIS OF GLUTAMATE DECARBOXYLASE IN POST-MORTEM BRAIN TISSUE IN HUNTINGTON'S CHOREA (1975) (0)
Amphetamine psychosis:how research on amphetamines provided new insights into the brain mechanisms underlying schizophrenia (2008) (0)
Tritiated Peptides. Part 12. Synthesis and Biological Activity of [4-3H-Phe8]Substance P. (1983) (0)
Factors influencing the development of the sympathetic nervous system: trans-synaptic regulation and the influence of nerve growth factor. (1972) (0)
Pathologic Heterogeneity of Alzheimer's Disease-Reply (1988) (0)
Drugs from peptides (1988) (0)
Biosynthesis and inactivation of the adrenergic transmitter substance. (1969) (0)
Principles and Methods of Behavioral Pharmacology (2009) (0)
Pharmacology. Medical uses of marijuana? (1993) (0)
What are amphetamines and how do they work in the brain (2008) (0)
Editorial Board (2007) (0)
BOOK REVIEW Introduction to Neuro- psychopharmacology (2009) (0)
NEUROPSYCHOPHARMACOLOGY. PROCEEDINGS OF THE IX CONGRESS OF THE 'COLLEGIUM INTERNATIONALE NEUROPSYCHOPHARMACOLOGICUM', PARIS, 7-12 JULY, 1974 (1975) (0)
2475 – GABA IN HUNTINGTON'S DISEASE AND SCHIZOPHRENIA (1978) (0)
4. Recreational drugs (2001) (0)
How do antipsychotic drugs work? (1975) (0)
Medical uses of amphetamines (2008) (0)
Synthesis and Pharmacological Evaluation of a Series of Dibenzo(a,d)cycloalkenimines as N‐Methyl‐D‐aspartate Antagonists. (1990) (0)
A holistic approach to the classification of behaviour (1980) (0)
2. How drugs work (2001) (0)
Drugs of abuse (1978) (0)
Les enigmes du cerveau (1989) (0)
Determination off the potencies of the R-(+) and S-(−) enantiomers off HA-966 as antagonists of the glycine site on the NMDA receptor complex (1990) (0)
Book Review:Glutamate as a Neurotransmitter. Gaetano Di Chiara, G. L. Gessa, E. Costa, Paul Greengard (1981) (0)
Acridology in the Uvarovian Style. (Book Reviews: Grasshoppers and Locusts. A Handbook of General Acridology. Vol. 2, Behaviour, Ecology, Biogeography, Population Dynamics) (1977) (0)
Book Review: Scientific Basis of Dvug Dependence (1970) (0)
Seminal Molecules (1968) (0)
The Biochemistry of Psychiatric Disturbances edited by G. Curzon. John Wiley & Sons, Chichester, 1980, 144 pp. ISBN 0471-278-14-9, £13.00. (1981) (0)
Nabilone Effective in Treating Pain in Upper Motor Neuron Syndromes (2007) (0)
Immunosympathectomy. A meeting, Milan, 1969. George Steiner and Eduard Schönbaum, Eds. Elsevier, New York, 1972. xiv, 254 pp., illus. $27.50 (1973) (0)
Is Cannabis Safe? (2018) (0)
Actions of dopaminergic drugs on dopamine stimulated adenosine 3',5' monophosphate production in rat neostriatum and limbic forebrain (1975) (0)
Recreational Psychoactive Drugs (2009) (0)
Substance P-Stimulated Phosphatidylinositol Breakdown in Guinea Pig Ileum (1984) (0)
How dangerous are the amphetamines (2008) (0)
METABOLlSM OF CATECHOLAMINES (1970) (0)
Drugs: A Very Short Introduction (2nd edn) (2016) (0)

This paper list is powered by the following services:

Other Resources About Leslie Iversen

en.wikipedia.org

What Schools Are Affiliated With Leslie Iversen?

Leslie Iversen is affiliated with the following schools: